JP2024547122A5 - - Google Patents

Info

Publication number
JP2024547122A5
JP2024547122A5 JP2024538148A JP2024538148A JP2024547122A5 JP 2024547122 A5 JP2024547122 A5 JP 2024547122A5 JP 2024538148 A JP2024538148 A JP 2024538148A JP 2024538148 A JP2024538148 A JP 2024538148A JP 2024547122 A5 JP2024547122 A5 JP 2024547122A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
sequence
nos
acid sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024538148A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024547122A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/140958 external-priority patent/WO2023116813A1/en
Publication of JP2024547122A publication Critical patent/JP2024547122A/ja
Publication of JP2024547122A5 publication Critical patent/JP2024547122A5/ja
Pending legal-status Critical Current

Links

JP2024538148A 2021-12-22 2022-12-22 抗tnfr2抗体及びその使用 Pending JP2024547122A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2021140487 2021-12-22
CNPCT/CN2021/140487 2021-12-22
PCT/CN2022/140958 WO2023116813A1 (en) 2021-12-22 2022-12-22 Anti-tnfr2 antibodies and uses thereof

Publications (2)

Publication Number Publication Date
JP2024547122A JP2024547122A (ja) 2024-12-26
JP2024547122A5 true JP2024547122A5 (cg-RX-API-DMAC7.html) 2026-01-06

Family

ID=86877889

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024538148A Pending JP2024547122A (ja) 2021-12-22 2022-12-22 抗tnfr2抗体及びその使用

Country Status (8)

Country Link
US (1) US20250019454A1 (cg-RX-API-DMAC7.html)
EP (1) EP4453035A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024547122A (cg-RX-API-DMAC7.html)
KR (1) KR20240123800A (cg-RX-API-DMAC7.html)
CN (2) CN116333123B (cg-RX-API-DMAC7.html)
AU (1) AU2022420151A1 (cg-RX-API-DMAC7.html)
CA (1) CA3236748A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023116813A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116333123B (zh) * 2021-12-22 2026-08-07 宝船生物医药科技(上海)有限公司 抗tnfr2抗体及其用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9221902B2 (en) * 2008-11-07 2015-12-29 Fabrus, Inc. Combinatorial antibody libraries and uses thereof
DK3447075T3 (da) * 2015-05-15 2023-11-13 Massachusetts Gen Hospital Antagonistiske antistoffer af antitumornekrosefaktorreceptor-superfamilien
KR20250007678A (ko) * 2016-05-13 2025-01-14 더 제너럴 하스피탈 코포레이션 길항성 항-종양 괴사 인자 수용체 슈퍼패밀리 항체
US11389480B2 (en) * 2017-05-19 2022-07-19 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Human monoclonal antibody targeting TNFR2 for cancer immunotherapy
US20210371537A1 (en) * 2018-09-18 2021-12-02 Merrimack Pharmaceuticals, Inc. Anti-tnfr2 antibodies and uses thereof
CN118667024A (zh) * 2018-11-01 2024-09-20 生物发明国际公司 新型拮抗性抗tnfr2抗体分子
EP3907240A4 (en) * 2019-08-02 2023-02-22 Jiangsu Simcere Pharmaceutical Co., Ltd. ANTI-TNFR2 ANTIBODIES AND USE THEREOF
AU2020348224A1 (en) * 2019-09-17 2022-05-12 Apexigen, Inc. Anti-TNFR2 antibodies and methods of use
CN112480259B (zh) * 2021-02-05 2021-05-04 百奥赛图(北京)医药科技股份有限公司 抗tnfr2抗体及其用途
CN116333123B (zh) * 2021-12-22 2026-08-07 宝船生物医药科技(上海)有限公司 抗tnfr2抗体及其用途

Similar Documents

Publication Publication Date Title
JP2023549537A5 (cg-RX-API-DMAC7.html)
JP2022515318A5 (cg-RX-API-DMAC7.html)
JP2019501883A5 (cg-RX-API-DMAC7.html)
JP2020515239A5 (cg-RX-API-DMAC7.html)
RU2019128134A (ru) Антитело против gprc5d и молекула, содержащая антитело
JP2021510736A5 (cg-RX-API-DMAC7.html)
JP2023549851A5 (cg-RX-API-DMAC7.html)
JP2024541680A5 (cg-RX-API-DMAC7.html)
JP2020500834A5 (cg-RX-API-DMAC7.html)
JP2022512642A5 (cg-RX-API-DMAC7.html)
JP2025503229A5 (cg-RX-API-DMAC7.html)
JP2024016024A5 (cg-RX-API-DMAC7.html)
JP2023518153A5 (cg-RX-API-DMAC7.html)
IL276675B1 (en) Anti-pd-1 antibodies and uses thereof
JP2023549316A5 (cg-RX-API-DMAC7.html)
JP2023037000A5 (cg-RX-API-DMAC7.html)
JP2023545521A5 (cg-RX-API-DMAC7.html)
JP2023517794A5 (cg-RX-API-DMAC7.html)
JP2023517754A5 (cg-RX-API-DMAC7.html)
JP2024533457A5 (cg-RX-API-DMAC7.html)
JP2022513437A5 (cg-RX-API-DMAC7.html)
JP2025517737A5 (cg-RX-API-DMAC7.html)
RU2024118627A (ru) Антитела против tnfr2 и их применения
CA3253250A1 (en) MEDICINE COMPRISING A COMBINATION OF MUTANT ANTI-CALR ANTIBODY AND ANOTHER MEDICINE
JP2025512025A5 (cg-RX-API-DMAC7.html)